Fusobacterium nucleatum may change tumor proliferation, invasion, metastasis, and drug resistance by increasing the expression of CXCL8 and reducing the expression of CXCL10, thus affecting the prognosis of patients. This evidence concerns the gene CXCL10 and neoplasm.